Tuberculosis vaccine H4IC (Valneva/Statens Serum Institut)

N/A

Report date: 2022/07/19 20:00:45

Base Information

Drug NameTuberculosis vaccine H4IC (Valneva/Statens Serum Institut)
Drug Alias Name结核疫苗H4IC - Valneva/Statens Serum InstitutH4/IC31 vaccineH4:IC31Tuberculosis vaccine H4IC,H4/AERAS-404+IC31Adjuvanted TB subunit vaccine H4IC +[9] 
ClassificationVaccines > Application > Prophylactic vaccine
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsLatent TuberculosisTuberculosisBacterial Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySwedenTanzaniaSouth Africa +[5] 
CombinationsNo
Global Highest StatusDiscontinued (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesStatens Serum Institut
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesStatens Serum InstitutAeras
Active IndicationsN/A
Inactive IndicationsLatent TuberculosisTuberculosisBacterial Infections

Other Information

ATC CodeN/A
Related LinksN/A